BankInvest Biomedical Venture

BankInvest Biomedical Venture is a venture capital firm in Denmark that invests in research-based biotechnology companies in Europe. Founded 1998 in Copenhagen, Denmark, this venture capital firm invests in early and late stage ventures. Its portfolio companies include F2G, Nereus Pharmaceuticals, Resistentia Pharmaceuticals, Cellectis, LiPlasome Pharma, and Genmab. As of February 2020, BankInvest Biomedical Venture has made 8 investments. Their most recent investment was on Aug 18, 2008, when F2G raised £6.3M. BankInvest Biomedical Venture has had 2 exits, the most notable of which include Genmab and Cellectis.